[HTML] mdpi.com

[HTML][HTML] Methylglyoxal-Modified Albumin Effects on Endothelial Arginase Enzyme and Vascular Function

EM Alzayadneh, A Shatanawi, RW Caldwell… - Cells, 2023 - mdpi.com
Advanced glycation end products (AGEs) contribute significantly to vascular dysfunction
(VD) in diabetes. Decreased nitric oxide (NO) is a hallmark in VD. In endothelial cells, NO is …
被引用次数：2 相关文章
[PDF] researchgate.net

[PDF][PDF] Methylglyoxal-Modified Albumin Effects on Endothelial Arginase Enzyme and Vascular Function. Cells 2023, 12, 795

EM Alzayadneh, A Shatanawi, RW Caldwell… - 2023 - researchgate.net
Advanced glycation end products (AGEs) contribute significantly to vascular dysfunction
(VD) in diabetes. Decreased nitric oxide (NO) is a hallmark in VD. In endothelial cells, NO is …
[HTML] nih.gov

[HTML][HTML] Methylglyoxal-Modified Albumin Effects on Endothelial Arginase Enzyme and Vascular Function

EM Alzayadneh, A Shatanawi, RW Caldwell… - Cells, 2023 - ncbi.nlm.nih.gov
Advanced glycation end products (AGEs) contribute significantly to vascular dysfunction
(VD) in diabetes. Decreased nitric oxide (NO) is a hallmark in VD. In endothelial cells, NO is …

Methylglyoxal-Modified Albumin Effects on Endothelial Arginase Enzyme and Vascular Function

EM Alzayadneh, A Shatanawi, RW Caldwell… - Cells, 2023 - search.proquest.com
Advanced glycation end products (AGEs) contribute significantly to vascular dysfunction
(VD) in diabetes. Decreased nitric oxide (NO) is a hallmark in VD. In endothelial cells, NO is …

Methylglyoxal-Modified Albumin Effects on Endothelial Arginase Enzyme and Vascular Function.

EM Alzayadneh, A Shatanawi, RW Caldwell… - Cells (2073 …, 2023 - search.ebscohost.com
Advanced glycation end products (AGEs) contribute significantly to vascular dysfunction
(VD) in diabetes. Decreased nitric oxide (NO) is a hallmark in VD. In endothelial cells, NO is …

Methylglyoxal-Modified Albumin Effects on Endothelial Arginase Enzyme and Vascular Function

E Alzayadneh, A Shatanawi, R Caldwell - Cells, 2023 - europepmc.org
Advanced glycation end products (AGEs) contribute significantly to vascular dysfunction
(VD) in diabetes. Decreased nitric oxide (NO) is a hallmark in VD. In endothelial cells, NO is …

Methylglyoxal-Modified Albumin Effects on Endothelial Arginase Enzyme and Vascular Function

EM Alzayadneh, A Shatanawi, RW Caldwell… - Cells, 2023 - pubmed.ncbi.nlm.nih.gov
Advanced glycation end products (AGEs) contribute significantly to vascular dysfunction
(VD) in diabetes. Decreased nitric oxide (NO) is a hallmark in VD. In endothelial cells, NO is …

Methylglyoxal-Modified Albumin Effects on Endothelial Arginase Enzyme and Vascular Function

EM Alzayadneh, A Shatanawi, RW Caldwell… - Cells, 2023 - augusta.elsevierpure.com
Advanced glycation end products (AGEs) contribute significantly to vascular dysfunction
(VD) in diabetes. Decreased nitric oxide (NO) is a hallmark in VD. In endothelial cells, NO is …

Methylglyoxal-Modified Albumin Effects on Endothelial Arginase Enzyme and Vascular Function.

EM Alzayadneh, A Shatanawi, RW Caldwell… - Cells, 2023 - europepmc.org
Advanced glycation end products (AGEs) contribute significantly to vascular dysfunction
(VD) in diabetes. Decreased nitric oxide (NO) is a hallmark in VD. In endothelial cells, NO is …